p21^waf correlates with DNA replication but not with prognosis in invasive breast cancer

U-J Göhring, A Bersch, M Becker, W Neuhaus and T Schöndorf

Department of Gynecology and Obstetrics, University of Cologne, 50924 Cologne, Germany

Correspondence to:
Dr Schöndorf thomas.schoendorf{at}medizin.uni-koeln.de

Background/Aims—p21^waf plays a central role both in the regulation of the cell cycle and in DNA replication. Accordingly, p21^waf is a putative tumour suppressor. The role of p21^waf expression in breast cancer is still unclear, particularly with respect to the clinical situation. Therefore, this retrospective study was designed to investigate the value of immunohistochemically detected p21^waf expression in invasive breast cancer.

Methods—Cellular expression of p21^waf was assessed in 307 breast cancer tissues by immunohistochemistry using the monoclonal antibody, clone 4D10. The data were correlated to established and functional factors of prognosis (age, menopausal status, tumour size, nodal status, tumour grade, receptor status, proliferating cell nuclear antigen (PCNA) expression, Her-2/neu expression, and p53 expression), and to clinical follow up (median observation time, 82 months).

Results—Ninety nine of 307 (32.2%) tumour tissues were considered p21^waf positive (nuclear staining). In the entire study group, p21^waf expression correlated only with increased PCNA expression (² test: p = 0.029), and with none of the other investigated markers. In node negative patients (n = 134), p21^waf expression correlated with increased tumour size and increased PCNA expression, whereas the node positive subgroup (n = 161) showed no correlation with these parameters (lymphonodectomy was done in 295 women). With respect to clinical outcome, p21^waf expression showed a definite favourable trend in both subgroups (N0: p21^waf negative, 23 of 87; p21^waf positive, nine of 43. N+: p21^waf negative, 63 of 107; p21^waf positive, 23 of 52), but this observation was not significant (p > 0.05). Multivariate analysis for disease free survival as indicated by Cox regression analysis included all factors investigated. The most striking parameters were nodal status (relative risk (RR), 1.74; p = 0.00001), receptor status (RR, 0.59; p = 0.0085), tumour size (RR, 1.42; p = 0.02), and Her2/neu expression (RR, 1.56; p = 0.033). p21^waf expression was not significant in the multivariate analysis (p > 0.05).

Conclusions—p21^waf expression is an independent factor but fails to be of prognostic or predictive value in multivariate analysis. These data confirm the hypothesis of a p53 independent p21^waf induction and suggest a functional role in the inhibition of PCNA mediated DNA replication.

Key Words: p21^waf • proliferating cell nuclear antigen • p53 • breast cancer • immunohistochemistry • prognosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Etemad-Moghadam, S., Baghaee, F., Tirgary, F., Motahhary, P., Khalili, M., Eshghyar, N., Alaedini, M., Eslami, M. (2007). Expression of p21WAF in Salivary Gland Mucoepidermoid Carcinoma and Its Relation to Histologic Grade. INT J SURG PATHOL 15: 6-13 [Abstract]  
• Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D., Piccart, M. J. (2005). Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?. Ann Oncol 16: 1723-1739 [Abstract] [Full Text]  
• Butt, A. J, McNeil, C. M, Musgrove, E. A, Sutherland, R. L (2005). Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12: S47-S59 [Abstract] [Full Text]  
• Xia, W., Chen, J.-S., Zhou, X., Sun, P.-R., Lee, D.-F., Liao, Y., Zhou, B. P., Hung, M.-C. (2004). Phosphorylation/Cytoplasmic Localization of p21Cip1/WAF1 Is Associated with HER2/neu Overexpression and Provides a Novel Combination Predictor for Poor Prognosis in Breast Cancer Patients. Clin. Cancer Res. 10: 3815-3824 [Abstract] [Full Text]  
• Pellikainen, M J, Pekola, T T, Ropponen, K M, Kataja, V V, Kellokoski, J K, Eskelinen, M J, Kosma, V-M (2003). p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J. Clin. Pathol. 56: 214-220 [Abstract] [Full Text]  
• Osman, I., Sherman, E., Singh, B., Venkatraman, E., Zelefsky, M., Bosl, G., Scher, H., Shah, J., Shaha, A., Kraus, D., Cordon-Cardo, C., Pfister, D. G. (2002). Alteration of p53 Pathway in Squamous Cell Carcinoma of the Head and Neck: Impact on Treatment Outcome in Patients Treated With Larynx Preservation Intent. JCO 20: 2980-2987 [Abstract] [Full Text]